Dr. Sumant Inamdar, MBBS, MD, MPH

Dr. Inamdar practices at UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences.

Dr. Inamdar's NPI, 1346472917, was assigned on August 17, 2009. Dr. Inamdar holds Arkansas license E-10523.

Dr. Inamdar's primary practice is UAMS Medical Center, at 4301 West Markham Street Mail Slot 612, Little Rock, AR 72205 in Pulaski County. The practice phone is (501) 686-5000.

Dr. Inamdar's primary practice is UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences. The medical group on file is UAMS - University of Arkansas for Medical Sciences. Dmand AI also links Dr. Inamdar to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Inamdar practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Inamdar's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Inamdar is licensed in Arkansas.

CMS data shows 801 Medicare services from Dr. Inamdar across 21 procedure codes in 2024, for 335 Medicare patients. Medicare paid $73,530 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 335 Medicare patients who saw Dr. Inamdar in 2024. The largest group is 65 to 74, with 135 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Inamdar's median patient age at 65, with 56% women.

In 2024, Dr. Inamdar wrote 120 Medicare Part D claims for 49 patients. 91% of them were for generic drugs. CMS names the drug for 87 of them, across 4 drugs with 11 or more claims each, at $2,028 in total drug cost. In 2023, CMS named 89 claims across 3 drugs.

Dr. Inamdar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 632 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Inamdar, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 128 papers to Dr. Inamdar, published from 2011 to 2025. 2024 was the busiest year, with 15. The most frequent topics are Cholangiopancreatography, Endoscopic Retrograde, Endosonography and Endoscopy, Gastrointestinal. Dr. Inamdar has published most often in Endoscopy. Dr. Inamdar's most frequent co-authors are Divyesh V. Sejpal, MD, Benjamin Tharian, MD and Hemant Goyal, MD.

Dmand AI links Dr. Inamdar to 1 clinical trial.

CMS Open Payments shows 35 general payments to Dr. Inamdar from 10 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 44% of the total. Pentax of America, Inc. paid the most, $3,068.